Manuel Peitsch discusses knowledge management and informatics in drug discovery

Drug Discovery Today: BIOSILICO

Volumn 2, Issue 3, 2004, Pages 94-96

  Peitsch, Manuel C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bioinformatics; bioinformatics; Drug Discovery; knowledge management; predicting protein structures; protein modelling; SWISS MODEL; Techniques Methods

Indexed keywords

APOPTOSIS; BIOINFORMATICS; COMPUTER PROGRAM; DRUG INDUSTRY; DRUG INFORMATION; GENE FUNCTION; MOLECULAR BIOLOGY; NOTE; PROTEIN STRUCTURE; T LYMPHOCYTE;

EID: 12444302237     PISSN: 17418364     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1741-8364(04)02407-2     Document Type: Note

References (1)

1. Vangrevelinghe E., et al. Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. J. Med. Chem. 46:2003;2656-2662